SCHEMBL15933225

SCHEMBL15933225

NBc1ccc(Cl)cc1CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.41
▸ IDO1 P14902 6/20 0.41
▸ ALOX15 P16050 4/20 0.41
▸ HIF1A Q16665 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ HTT P42858 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALOX12 P18054 2/20 0.41
▸ SLC22A1 O15245 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ HSPD1 P10809 1/20 0.41
▸ HSPA5 P11021 1/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ HSPE1 P61604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20459459 0.82 MAPT (0.46) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL22942635 0.80 MAPT (0.41) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL29493203 0.73 IDO1 (0.50) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL1154758 0.73 IDO1 (0.50) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL16683593 0.73 CYP1A2 (0.37) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL703030 0.72 CYP3A4 (0.52) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL92968 0.72 CYP3A4 (0.48) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL4574317 0.71 IDO1 (0.43) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL1307331 0.71 IDO1 (0.43) MAPTIDO1ALOX15HIF1AHPGD
SCHEMBL29825244 0.70 MAPT (0.50) MAPTIDO1ALOX15HIF1AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140221631-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2014-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221631-A1 BORON-CONTAINING SMALL MOLECULES ETF1, POLR1C, DPM1 MAPT 1768/4885IDO1 352/4885ALOX15 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback